TGFB1 and cancer: In addition, Non-canonical TGF-β has been reported to activate non-Smad pathways, including MAPK, YAP/TAZ, PI3K/Akt, and AMPK signaling, leading to fibrosis, immune evasion, and EMT, ultimately promoting cancer progression [226].